Degenerative and inflammatory markers in the cerebrospinal fluid of multiple sclerosis patients with relapsing-remitting course of disease and after clinical isolated syndrome

被引:27
|
作者
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Zapletalova, Jana [1 ]
Stejskal, David [1 ]
Hlustik, Petr [1 ]
Kanovsky, Petr [1 ]
机构
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
关键词
Multiple sclerosis; CIS; RRMS; CSF; Inflammatory markers; Degenerative markers; TAU-PROTEIN; AXONAL DAMAGE; CYSTATIN-C; SUBGROUPS;
D O I
10.1179/016164110X12816242542535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Literature includes evidence of initial predominance of inflammation and later development of neurodegeneration in the pathogenesis of multiple sclerosis (MS). Objective: To search for differences in inflammatory and degenerative cerebrospinal fluid (CSF) markers between relapsing-remitting MS (RRMS) and the clinical isolated syndrome (CIS). Methods: A total of 148 subjects were evaluated, 65 MS patients (45 RRMS and 20 CIS) and 83 controls. The evaluated parameters included albumin quotient and prealbumin, transferrin, C3 and C4 complement factors, haptoglobin, beta-2-microglobulin, orosomucoid, alpha-1-antitrypsin, apolipoprotein A-I, apolipoprotein B, cystatin C, neuron-specific enolase, tau protein, beta-amyloid, oligoclonal IgG band (OCB), and IgG quotient (QIgG). Results: No differences were found in the inflammatory and degenerative CSF markers between patients with RRMS and CIS. QIgG was higher in RRMS than that in CIS but the number of OCB was higher after CIS. Cystatin C levels were significantly lower in RRMS compared to the other groups. It can be considered an indicator of the demyelination degree. Normal values of beta-amyloid were less frequent in RRMS compared to those in controls.
引用
收藏
页码:415 / 420
页数:6
相关论文
共 50 条
  • [21] Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Floris, S
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    Lamers, KJB
    MULTIPLE SCLEROSIS, 1998, 4 (03): : 108 - 110
  • [22] Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis
    Beyer, Natascha Helena
    Lueking, Angelika
    Kowald, Axel
    Frederiksen, Jette Lautrup
    Heegaard, Niels H. H.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 242 (1-2) : 26 - 32
  • [23] Clinical effects of interferon β in relapsing-remitting multiple sclerosis in view of natural course of the disease
    Pokryszko-Dragan, A
    Biliñska, M
    Gruszka, E
    Dubik-Jezierzañska, M
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S237 - S237
  • [24] Apoptosis of cerebrospinal fluid lymphocytes in patients with relapsing-remitting, primary and secondary progressive multiple sclerosis
    Petelin, Z
    Brinar, V
    Zurak, N
    Dubravcic, K
    Botinic, D
    Ivankovic, D
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S125 - S126
  • [25] Stratification of relapsing-remitting multiple sclerosis patients by 2-DE analysis of cerebrospinal fluid
    Perga, S.
    Albo, A. Giuliano
    Lis, K.
    Minari, N.
    Reviglione, R.
    Falvo, S.
    Marnetto, F.
    Gilli, F.
    Capobianco, M.
    Malentacchi, M.
    Corpillo, D.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S267 - S268
  • [26] Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis
    Rejdak, K.
    Petzold, A.
    Kocki, T.
    Kurzepa, J.
    Grieb, P.
    Turski, W. A.
    Stelmasiak, Z.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (08) : 1011 - 1015
  • [27] Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis
    K. Rejdak
    A. Petzold
    T. Kocki
    J. Kurzepa
    P. Grieb
    W. A. Turski
    Z. Stelmasiak
    Journal of Neural Transmission, 2007, 114 : 1011 - 1015
  • [28] Course of relapsing-remitting multiple sclerosis before, during and after natalizumab
    Kaufman, Michael D.
    Lee, R.
    Norton, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (04) : 490 - 494
  • [29] Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis
    Ahlbrecht, Jonas
    Martino, Filippo
    Pul, Refik
    Skripuletz, Thomas
    Suehs, Kurt-Wolfram
    Schauerte, Celina
    Yildiz, Oezlem
    Trebst, Corinna
    Tasto, Lars
    Thum, Sabrina
    Pfanne, Angelika
    Roesler, Romy
    Lauda, Florian
    Hecker, Michael
    Zettl, Uwe K.
    Tumani, Hayrettin
    Thum, Thomas
    Stangel, Martin
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (09) : 1202 - 1214
  • [30] Degenerative markers in cerebrospinal fluid in multiple sclerosis patients
    Sladkova, V.
    Mares, J.
    Lubenova, B.
    Kollarova, K.
    Opavsky, R.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2008, 255 : 82 - 83